Express Scripts Holding Company (NASDAQ: ESRX) Stock Competitors & Peer Comparison
See ESRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ESRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESRX | $92.33 | +0.00% | 0 | 10.69 | $8.64 | N/A |
| RPRX | $61.73 | +3.42% | 27.4B | 11.76 | $5.25 | +1.50% |
| CORT | $119.02 | +0.78% | 12.9B | 340.06 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $75.33 | +1.35% | 6.7B | 538.07 | $0.14 | N/A |
| KNSA | $80.80 | +1.65% | 6.2B | 89.78 | $0.90 | N/A |
| TRLV | $10.09 | +4.13% | 1.7B | -24.10 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $20.94 | +4.70% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
ESRX vs RPRX Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, RPRX has a market cap of 27.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while RPRX trades at $61.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas RPRX's P/E ratio is 11.76. In terms of profitability, ESRX's ROE is +0.26%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, ESRX is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
ESRX vs CORT Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CORT has a market cap of 12.9B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CORT trades at $119.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CORT's P/E ratio is 340.06. In terms of profitability, ESRX's ROE is +0.26%, compared to CORT's ROE of +0.08%. Regarding short-term risk, ESRX is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
ESRX vs WBA Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas WBA's P/E ratio is -1.64. In terms of profitability, ESRX's ROE is +0.26%, compared to WBA's ROE of -0.42%. Regarding short-term risk, ESRX is similarly volatile compared to WBA. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
ESRX vs LQDA Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LQDA has a market cap of 6.7B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LQDA trades at $75.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LQDA's P/E ratio is 538.07. In terms of profitability, ESRX's ROE is +0.26%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, ESRX is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
ESRX vs KNSA Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, KNSA has a market cap of 6.2B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while KNSA trades at $80.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas KNSA's P/E ratio is 89.78. In terms of profitability, ESRX's ROE is +0.26%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, ESRX is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
ESRX vs TRLV Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, TRLV has a market cap of 1.7B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while TRLV trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas TRLV's P/E ratio is -24.10. In terms of profitability, ESRX's ROE is +0.26%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, ESRX is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
ESRX vs HROWL Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HROWL's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, ESRX is less volatile compared to HROWL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
ESRX vs HROWM Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HROWM's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, ESRX is less volatile compared to HROWM. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
ESRX vs LTGO Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LTGO has a market cap of 1.3B. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LTGO trades at $20.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LTGO's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to LTGO's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
ESRX vs CUVL Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CUVL has a market cap of 360.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CUVL trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CUVL's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to CUVL's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
ESRX vs LFMD Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LFMD has a market cap of 164.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LFMD trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LFMD's P/E ratio is -6.80. In terms of profitability, ESRX's ROE is +0.26%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, ESRX is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
ESRX vs LFMDP Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LFMDP has a market cap of 158.8M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LFMDP trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LFMDP's P/E ratio is -717.72. In terms of profitability, ESRX's ROE is +0.26%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, ESRX is less volatile compared to LFMDP. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
ESRX vs CIRC Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CIRC has a market cap of 58.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CIRC trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CIRC's P/E ratio is -1.48. In terms of profitability, ESRX's ROE is +0.26%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, ESRX is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CIRC's competition here
Stablecoin Development Corp. (AMEX: SDEV)
ESRX vs SDEV Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SDEV has a market cap of 52M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SDEV trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SDEV's P/E ratio is -0.18. In terms of profitability, ESRX's ROE is +0.26%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, ESRX is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SDEV's competition here
Rite Aid Corporation (NYSE: RAD)
ESRX vs RAD Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas RAD's P/E ratio is -0.05. In terms of profitability, ESRX's ROE is +0.26%, compared to RAD's ROE of +2.76%. Regarding short-term risk, ESRX is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
ESRX vs GLTO Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas GLTO's P/E ratio is -1.78. In terms of profitability, ESRX's ROE is +0.26%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, ESRX is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
ESRX vs SCYX Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SCYX has a market cap of 32.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SCYX trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SCYX's P/E ratio is -1.51. In terms of profitability, ESRX's ROE is +0.26%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, ESRX is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
ESRX vs NSRX Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, NSRX has a market cap of 32.3M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while NSRX trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas NSRX's P/E ratio is -5.21. In terms of profitability, ESRX's ROE is +0.26%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, ESRX is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check NSRX's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
ESRX vs AIXC Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, AIXC has a market cap of 31.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while AIXC trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas AIXC's P/E ratio is -0.17. In terms of profitability, ESRX's ROE is +0.26%, compared to AIXC's ROE of -0.97%. Regarding short-term risk, ESRX is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check AIXC's competition here
Cerenome, Inc. (NASDAQ: CNSY)
ESRX vs CNSY Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CNSY has a market cap of 22M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CNSY trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CNSY's P/E ratio is -0.44. In terms of profitability, ESRX's ROE is +0.26%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, ESRX is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
ESRX vs BFRI Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BFRI has a market cap of 18.2M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BFRI trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BFRI's P/E ratio is -2.58. In terms of profitability, ESRX's ROE is +0.26%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, ESRX is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
ESRX vs CJJD Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CJJD's P/E ratio is -0.46. In terms of profitability, ESRX's ROE is +0.26%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, ESRX is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
ESRX vs SSY Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SSY's P/E ratio is -2.86. In terms of profitability, ESRX's ROE is +0.26%, compared to SSY's ROE of -0.09%. Regarding short-term risk, ESRX is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
ESRX vs POM Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, POM has a market cap of 7.1M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while POM trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas POM's P/E ratio is -0.21. In terms of profitability, ESRX's ROE is +0.26%, compared to POM's ROE of +0.16%. Regarding short-term risk, ESRX is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
ESRX vs PAVS Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, PAVS has a market cap of 5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while PAVS trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas PAVS's P/E ratio is -0.07. In terms of profitability, ESRX's ROE is +0.26%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, ESRX is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check PAVS's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
ESRX vs BGMS Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BGMS trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BGMS's P/E ratio is -0.25. In terms of profitability, ESRX's ROE is +0.26%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, ESRX is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BGMS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
ESRX vs HKPD Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, HKPD has a market cap of 4.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while HKPD trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas HKPD's P/E ratio is -6.71. In terms of profitability, ESRX's ROE is +0.26%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, ESRX is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check HKPD's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
ESRX vs MDVL Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas MDVL's P/E ratio is -0.05. In terms of profitability, ESRX's ROE is +0.26%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, ESRX is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
ESRX vs ATNFW Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas ATNFW's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, ESRX is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
ESRX vs BGMSP Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, ESRX's ROE is +0.26%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, ESRX is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
ESRX vs AZNH Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas AZNH's P/E ratio is 38.35. In terms of profitability, ESRX's ROE is +0.26%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, ESRX is less volatile compared to AZNH. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
ESRX vs LFLYW Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, ESRX's ROE is +0.26%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, ESRX is similarly volatile compared to LFLYW. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
ESRX vs SBFMW Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SBFMW has a market cap of 249.8K. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SBFMW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SBFMW's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to SBFMW's ROE of -0.24%. Regarding short-term risk, ESRX is similarly volatile compared to SBFMW. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check SBFMW's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
ESRX vs CPD Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, CPD has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas CPD's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to CPD's ROE of N/A. Regarding short-term risk, ESRX is less volatile compared to CPD. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check CPD's competition here
POZEN Inc. (NASDAQ: POZN)
ESRX vs POZN Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, POZN has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas POZN's P/E ratio is N/A. In terms of profitability, ESRX's ROE is +0.26%, compared to POZN's ROE of +0.61%. Regarding short-term risk, ESRX is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check POZN's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
ESRX vs IPXL Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, IPXL has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas IPXL's P/E ratio is -10.11. In terms of profitability, ESRX's ROE is +0.26%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, ESRX is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check IPXL's competition here
Shire plc (NASDAQ: SHPG)
ESRX vs SHPG Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, SHPG has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas SHPG's P/E ratio is 11.35. In terms of profitability, ESRX's ROE is +0.26%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, ESRX is similarly volatile compared to SHPG. This indicates similar risk in terms of short-term price fluctuations for ESRX.Check SHPG's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
ESRX vs OREX Comparison August 2026
Express Scripts Holding Company (NASDAQ: ESRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESRX stands at 0. In comparison, OREX has a market cap of 0. Regarding current trading prices, ESRX is priced at $92.33 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESRX currently has a P/E ratio of 10.69, whereas OREX's P/E ratio is -0.14. In terms of profitability, ESRX's ROE is +0.26%, compared to OREX's ROE of -0.54%. Regarding short-term risk, ESRX is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for ESRX.Check OREX's competition here